PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.75%
Negative revenue growth while Technology median is 3.48%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-8.29%
Negative gross profit growth while Technology median is 1.65%. Seth Klarman would suspect poor product pricing or inefficient production.
-0.24%
Negative EBIT growth while Technology median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
0.24%
Operating income growth of 0.24% while Technology median is zero. Walter Schloss might see a modest advantage that can expand.
9.66%
Net income growth of 9.66% while Technology median is zero. Walter Schloss might see potential if moderate gains can keep rising.
11.27%
EPS growth of 11.27% while Technology median is zero. Walter Schloss might see a slight edge that could compound over time.
8.45%
Diluted EPS growth of 8.45% while Technology median is zero. Walter Schloss might see a slight edge that could improve over time.
-1.01%
Share reduction while Technology median is 0.00%. Seth Klarman would see a relative advantage if others are diluting.
-0.59%
Diluted share reduction while Technology median is 0.00%. Seth Klarman would see an advantage if others are still diluting.
8.09%
Dividend growth of 8.09% while Technology median is flat. Walter Schloss might appreciate at least a modest improvement.
-6.68%
Negative OCF growth while Technology median is 3.26%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
0.76%
FCF growth of 0.76% while Technology median is zero. Walter Schloss might see a slight edge that could compound over time.
72.41%
10Y revenue/share CAGR exceeding 1.5x Technology median of 5.70%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
34.31%
5Y revenue/share growth exceeding 1.5x Technology median of 9.38%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
16.04%
3Y revenue/share growth exceeding 1.5x Technology median of 3.93%. Joel Greenblatt might see a short-term competitive advantage at play.
177.75%
OCF/share CAGR of 177.75% while Technology median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
85.39%
OCF/share CAGR of 85.39% while Technology median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
1.19%
3Y OCF/share growth of 1.19% while Technology median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
120.11%
Net income/share CAGR exceeding 1.5x Technology median of 36.17% over a decade. Joel Greenblatt might see a standout compounder of earnings.
96.83%
5Y net income/share CAGR > 1.5x Technology median of 29.80%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
46.06%
3Y net income/share CAGR > 1.5x Technology median of 17.28%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
22.64%
Equity/share CAGR of 22.64% while Technology median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
19.66%
5Y equity/share CAGR > 1.5x Technology median of 0.53%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
22.49%
3Y equity/share CAGR of 22.49% while Technology median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
511.63%
Dividend/share CAGR of 511.63% while Technology is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
336.24%
5Y dividend/share CAGR of 336.24% while Technology is zero. Walter Schloss sees at least some improvement that could compound over time.
29.79%
3Y dividend/share CAGR of 29.79% while Technology is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
-13.45%
AR shrinking while Technology median grows. Seth Klarman sees potential advantage unless it signals declining demand.
6.74%
Inventory growth of 6.74% while Technology median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
5.95%
Asset growth exceeding 1.5x Technology median of 1.34%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
5.84%
BV/share growth exceeding 1.5x Technology median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
No Data
No Data available this quarter, please select a different quarter.
-6.00%
R&D dropping while Technology median is rising. Seth Klarman wonders if we risk ceding future innovation or if peers overspend.
-0.26%
SG&A decline while Technology grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.